Mar 23, 2012
1:6
For every 6 shares held, investors received 1. The price per share adjusted from $0.74 to $0.12.
The split itself did not change the total investment value.
Galectin Therapeutics Inc. (GALT) trades on the NASDAQ Capital Market in the Biotechnology industry.
Galectin Therapeutics Inc. company overviewThe latest split shown was on March 23, 2012. It was a 1-for-6 reverse split, so shareholders received 1 share for every 6 they held.
This history records one reverse split, on March 23, 2012.